As a research-intensive global healthcare leader, MSD is committed to developing innovative medicines and vaccines that save lives and improve the health and well-being of people worldwide. With a significant footprint in the EU, we welcome the opportunity to emphasise the critical importance of the upcoming Biotech Act in shaping a competitive and future-proof biopharmaceutical ecosystem for Europe.
MSD
MSD
Company · Belgium · EU Transparency Register 09824113589-92
4
positions filed
in the 326 files tracked
4
legislative files
of 326 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 925 companies & groups on this site, they rank #213 by legislative files engaged — a count of participation, not a measure of influence.
6.2
declared lobbying FTE
self-declared
€1.8M+
declared costs / yr (floor)
12
EP accreditations
as declared to the register
2010
in the register since
Declares membership of
- MSD is a member of
- EFPIA →
- VE
- EuropaBio →
- AmCham EU
- Friends of Europe
- EURORDIS
- EAPM (European Alliance for personalised Medicine)
- CER (Centre for European Reform)
- EPC (European Policy Council)
- AECA (The American European Community Association)
- ACEBA (American-Central European Business Association)
- and 13 more
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Companies & groups
- Registered as
- Merck Sharp & Dohme Europe Belgium SRL (MSD)
- Head office
- Rahway, NJ, United states
- EU office
- Brussels
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track MSD in PolicySpeak: request access →
Work at MSD? so we know who speaks for it.
Their record over time
MSD filed 4 positions between 14 Mar 2024 and 18 May 2026, across 4 of the 326 legislative files tracked here, attaching a full position paper 1 time.
2024 · 1 filed2025 · 1 filed2026 · 2 filed
What they argued
On behalf of MSD, I am pleased to submit our contribution to the Call for Evidence on the forthcoming Council Recommendation on cardiovascular health checks. Cardiovascular diseases remain the leading cause of death in the EU, with a substantial share driven by atherosclerotic cardiovascular disease (ASCVD) linked to cumulative exposure to low-density lipoprotein cholesterol (LDL-C).
ABOUT MSD ANIMAL HEALTH MSD Animal Health is a global leader in animal health solutions, including technologies supporting fish health, disease prevention and traceability in aquaculture and fisheries. Through its work with fish farmers, researchers and public authorities, the company contributes to improving the sustainability, productivity and transparency of aquatic food systems.
As a One Health company, MSD Animal Health is committed to animal welfare and efficient farming. In addition to our vaccines and medicines portfolio, we are the leading the agritech company in the market, specialised in the developments of tools and technologies that allow for the electronic identification, monitoring and traceability of animals (livestock, fish, pets).
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- IDEE ECONOMICHE www.idee-economiche.it · 3 files in common
- Eurogroup for Animals · 3 files in common
- AnimalhealthEurope · 3 files in common
- MedTech Europe · 2 files in common
- Confederazione Nazionale Coldiretti · 2 files in common
Showing 5 of 35.
Is this your organization?
Everything on this page comes from MSD’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.